back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-06-01 18:03 Tx date 2023-05-15 |
$APLI
Appili Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+365,000 vol |
610,000 | |
| Filed 2023-01-12 13:54 Tx date 2023-01-04 |
$APLI
Appili Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-170,800
-140,000 vol $1.22 each |
245,000 | |
| Filed 2023-01-12 13:53 Tx date 2023-01-04 |
$APLI
Appili Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-140,000
-140,000 vol $1.00 each |
385,000 | |
| Filed 2021-12-13 14:05 Tx date 2021-12-08 |
$APLI
Appili Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,850
+245,000 vol $0.13 each |
525,000 | |
| Filed 2021-05-08 13:10 Tx date 2021-05-07 |
$APLI
Appili Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$170,800
+140,000 vol $1.22 each |
280,000 | |
| Filed 2021-02-03 21:46 Tx date 2021-01-31 |
$APLI
Appili Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$140,000
+140,000 vol $1.00 each |
140,000 | |
| Filed 2021-02-03 21:44 Tx date 2021-01-31 |
$APLI
Appili Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-03 21:43 Tx date 2021-01-31 |
$APLI
Appili Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-03 21:41 Tx date 2021-02-01 |
$APLI
Appili Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-11-20 Tx date 2015-11-18 |
$CTH
Cynapsus Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,992
+312 vol $16.00 each |
1,124 | |
| Filed 2015-11-20 Tx date 2015-11-18 |
$CTH
Cynapsus Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,992
-312 vol $16.00 each |
45,125 | |
| Filed 2015-09-22 Tx date 2015-09-18 |
$CTH
Cynapsus Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$321,000
+15,000 vol $21.40 each |
45,437 | |
| Filed 2015-09-03 Tx date 2015-08-31 |
$CTH
Cynapsus Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-10,000
-625 vol $16.00 each |
30,437 | |
| Filed 2015-09-03 Tx date 2015-08-31 |
$CTH
Cynapsus Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,000
+625 vol $16.00 each |
812 | |
| Filed 2015-06-24 Tx date 2015-06-23 |
$CTH
Cynapsus Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,813 vol |
187 | |
| Filed 2015-06-24 Tx date 2015-06-23 |
$CTH
Cynapsus Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-465,938 vol |
31,062 | |
| Filed 2015-05-15 Tx date 2015-05-15 |
$CTH
Cynapsus Therapeutics Inc. |
Stenzler, Rochelle
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-35,000 vol |
497,000 |